Anzeige
Mehr »
Mittwoch, 08.10.2025 - Börsentäglich über 12.000 News
Defence-Aktie mit Ritterschlag: Regierungs-Einladung zur größten Militärmesse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
30.09.J&J gets FDA approval for Tremfya in paediatric psoriasis
30.09.NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing
29.09.Amgen to invest $650m in US manufacturing network expansion
29.09.Regeneron's Evkeeza gains FDA approval for young HoFH patients
26.09.AstraZeneca launches DTC platform amid US pricing pressures
26.09.Drugmakers point to US expansion plans amid Trump's 100% drug tariff
26.09.FDA approves Lilly's Inluriyo to treat advanced breast cancer
26.09.European PE company prioritising CGT and other novel modality investments
26.09.Harmony's cannabidiol drug flops in pivotal Fragile X Syndrome trial
26.09.Synaffix and Qurient enter licensing deal for dual-payload ADC
25.09.MSD pays up to nearly $600m for Evaxion's mystery vaccine candidate
25.09.BMS expands DTC offering with Sotyktu addition
25.09.FDA delays approval decision for Sanofi's MS treatment tolebrutinib
25.09.Biogen's high-dose Spinraza turned down by FDA due to CMC troubles
25.09.Basilea in line for $159m of US federal funding for UTI antibiotic pill
25.09.Roche bids to broaden MS pipeline and strengthen Ocrevus influence
25.09.Sanofi announces $625m to venture capital arm
24.09.Eli Lilly to build $6.5bn orforglipron production site in Texas
24.09.Imunon's Phase III-stage IL-12 gene therapy alters tumour microenvironment in ovarian cancer
24.09.FDA to priority-review Daiichi Sankyo and AZ's Enhertu sBLA
24.09.TegMine and Boehringer Ingelheim partner on cancer therapeutics
23.09.FDA actions Tylenol label change after Trump's autism claim
23.09.Bill Gates pledges $912m to combat infectious diseases amid US funding cuts
23.09.Innovative mental health treatment tech struggles for traction as pharma dominates
23.09.EC approves Servier's Voranigo to treat IDH-mutant glioma